The US's first marketed CRISPR drug may be set to make its debut in a year or less, following CRISPR…
McAlinden Research PartnersSeptember 29, 2022
Defense Firms Set to Earn Billions of Dollars in New Contracts Amid Militarization of Eastern Europe
Military spending and US foreign aid is tilting heavily toward the EU and NATO's borderlands in the eastern part of the European…
McAlinden Research PartnersSeptember 20, 2022
The potential utility of solar power has been bolstered by major geopolitical struggle involving energy supplies. Natural gas reserves and…
McAlinden Research PartnersSeptember 12, 2022
The volume and cost of cyberattacks has continued to increase exponentially across the world over the past decade. The COVID-era…
McAlinden Research PartnersSeptember 1, 2022
The US is expected to announce their largest single military aid package to Ukraine on Wednesday. Reportedly worth $3 billion,…
McAlinden Research PartnersAugust 24, 2022
Zaporizhzhia Nuclear Power Plant is right on the front lines of Russia's invasion of Ukraine. Russia has maintained control of the…
McAlinden Research PartnersAugust 18, 2022
Commercial satellite imagery firms continue to provide significant utility to the US military via critical geospatial data regarding Russia's invasion…
McAlinden Research PartnersAugust 11, 2022
M&A activity is picking up among pharmaceutical firms with large cash balances. Pfizer and Amgen have each closed a multi-billion…
McAlinden Research PartnersAugust 9, 2022
Congress Could Soon Approve Billions of Dollars to Continue Developing US Solar Capacity, Production
The Inflation Reduction Act's provisions regarding renewable energy incentives are worth hundreds of billions of dollars. Perhaps the most critical…
McAlinden Research PartnersAugust 2, 2022
